Pharmaceuticals, Biotechnology and Life Sciences
Presentation to focus on potential use of AT-1501 in kidney transplantation as well as research collaboration between Eledon and CareDx…
First nine months 2021 financial results: Group revenues of €317.9 millionOperating loss of €175.7 millionNet loss of €119.6 millionCash and…
• Sponsored programs at ASH 2021 – preliminary clinical data to be presented at ASH 2021 for product candidate UCART22…
BERKELEY, Calif. and MAINZ, Germany, Nov. 04, 2021 (GLOBE NEWSWIRE) — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”),…
Monthly information regarding the total number of voting rights and total number of shares of the Company as of October…
Announces clinical collaboration with Roche for first line NSCLC Remains on track with clinical data milestone timing BOSTON, Nov. 04,…
WALTHAM, Mass., Nov. 04, 2021 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology…
Company Announcement Genmab improves its 2021 financial guidance COPENHAGEN, Denmark; November 4, 2021 – Genmab A/S (Nasdaq: GMAB) announced today…
Third Quarter Net Revenue of $2.6 MillionUp 24% Year-Over-Year and 16% Quarter-over-Quarter SOUTH ORANGE, NJ, Nov. 04, 2021 (GLOBE NEWSWIRE)…
-Initial data release from Phase 2 study of CX-2029 remains on track for fourth quarter 2021- -Initial data release from…